Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives.
Glaucoma is a leading cause of blindness worldwide. Currently, topical drops are the mainstay of treatment for patients who suffer from this chronic disease. Adherence to topical therapy is known to be affected by forgetfulness, frequent dosing requirements and physical limitations. Dosing and adherence aids are designed to help patients adhere to their prescribed therapeutic regimens. This review discusses commonly used dosing and adherence aids, and offers opinions on how future devices may improve on currently available technology.
Kahook
Malik Y
MY
Rocky Mountain Lions Eye Institute, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA. malik.kahook@gmail.com
D000287:Administration, Topical; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods* / Q000639:trends; D004867:Equipment Design / Q000639:trends; D005544:Forecasting; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D010349:Patient Compliance; D012646:Self Administration / Q000295:instrumentation* / Q000379:methods*